Rasagiline Tablet
Product Images NDC 33342-309

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 33342-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline-05mg.jpg (Rasagiline 05mg)

Rasagiline Tablets 0.5 mg oral dosage form, labeled by Macleods Pharmaceuticals Limited and manufactured for Macleods Pharma USA, Inc. The label includes dosage strength, storage instructions, barcode, and packaging for a 30-tablet count. The label displays the proprietary name Rasagiline and notes prescription use only.*

FDA Label Image

Rasagiline-1-mg.jpg (Rasagiline 1 mg)

Packaging label for Rasagiline Tablets 1 mg oral tablets by Macleods Pharmaceuticals Limited. The label indicates 30 tablets per container and includes storage instructions as well as manufacturer information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

Fig (Rasagiline Fig)

Chemical structure of the active ingredient rasagiline represented with its molecular components, including a bicyclic amine and a sulfonic acid group (CH3SO3H) indicated as part of its formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.